A detailed history of Alpha Centric Advisors LLC transactions in Mckesson Corp stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 205 shares of MCK stock, worth $118,926. This represents 0.08% of its overall portfolio holdings.

Number of Shares
205
Previous 233 12.02%
Holding current value
$118,926
Previous $107,000 2.8%
% of portfolio
0.08%
Previous 0.08%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

SELL
$473.42 - $539.26 $13,255 - $15,099
-28 Reduced 12.02%
205 $110,000
Q4 2023

Feb 14, 2024

SELL
$437.42 - $470.64 $297,445 - $320,035
-680 Reduced 74.48%
233 $107,000
Q3 2023

Nov 13, 2023

SELL
$402.4 - $446.42 $20,924 - $23,213
-52 Reduced 5.39%
913 $397,000
Q2 2023

Aug 08, 2023

BUY
$354.01 - $427.31 $82,838 - $99,990
234 Added 32.01%
965 $412,000
Q1 2023

May 12, 2023

SELL
$335.35 - $386.06 $4,024 - $4,632
-12 Reduced 1.62%
731 $260,000
Q4 2022

Feb 07, 2023

BUY
$346.68 - $397.58 $257,583 - $295,401
743 New
743 $279,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $83.4B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.